Table 4.
Univariate linear regression analysis with sUA.
| Beta | p | Lower 95% | Upper 95% | |
|---|---|---|---|---|
| Clinical | ||||
| Age | 0.012 | 0.87 | −0.013 | 0.016 |
| Gender | 0.330 | 0.001 | 0.488 | 1.214 |
| Weight | 0.235 | 0.001 | 0.007 | 0.029 |
| BMI | 0.162 | 0.03 | 0.003 | 0.071 |
| HR | 0.007 | 0.93 | −0.015 | 0.016 |
| SBP | 0.068 | 0.36 | −0.005 | 0.015 |
| DBP | 0.083 | 0.30 | −0.007 | 0.025 |
| ABI | −0.096 | 0.23 | −2.214 | 0.539 |
| Pulse pressure | 0.022 | 0.77 | −0.012 | 0.016 |
| Duration of hypertension | 0.061 | 0.45 | −0.016 | 0.038 |
| Serum biochemistry | ||||
| TC | 0.0047 | 0.36 | −0.007 | 0.003 |
| HDL | 0.13 | <0.001 | −0.04 | -0.016 |
| LDL | 0.0015 | 0.60 | −0.007 | 0.004 |
| Triglycerides | 0.08 | <0.001 | 0.003 | 0.009 |
| sGlucose | 0.03 | 0.02 | 0.002 | 0.018 |
| sCreatinine | 0.12 | <0.001 | 1.182 | 2.779 |
| sUrea | 0.026 | 0.03 | 0.002 | 0.035 |
| eGFR | 0.026 | 0.03 | −0.006 | 0.005 |
| Cardiac ultrasound | ||||
| LVMi | 0.186 | 0.01 | 0.005 | 0.032 |
| LV ejecton fraction | 0.0043 | 0.39 | −0.028 | 0.011 |
| RWT | <0.001 | 0.96 | −2.032 | 2.505 |
| LAD | 0.015 | 0.12 | −0.008 | 0.058 |
| E/A | 0.0005 | 0.78 | −0.772 | 0.578 |
| DT | 0.006 | 0.36 | −0.002 | 0.006 |
| IVSd | 0.02 | 0.09 | 0.035 | 0.212 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; ABI, ankle-brachial index; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; sGlucose, serum glucose; sCreatinine, serum creatinine; sUrea, serum urea; eGFR, estimated glomerular filtration rate; LVMi, left ventricular mass index; RWT, relative wall thickness; LAD, left atrial diameter; E, early-wave transmitral diastolic velocity; A, late-wave transmitral diastolic velocity; DT, deceleration time; IVSd, diastolic intraventricular septum diameter. Bold values indicate statistical significance (p < 0.05).